The immune checkpoints Cytotoxic T lymphocyte antigen‐4 and Lymphocyte activation gene‐3 expression is up‐regulated in acute myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The immune checkpoints Cytotoxic T lymphocyte antigen‐4 and Lymphocyte activation gene‐3 expression is up‐regulated in acute myeloid leukemia

Published:2020-03-29 Issue:1 Volume:96 Page:3-12
ISSN:2059-2302
Container-title:HLA
language:en
Short-container-title:HLA

Author:

Radwan Sara M.¹^ORCID,Elleboudy Nooran S.²,Nabih Nermeen A.³,Kamal Amany M.¹

Affiliation:

1. Biochemistry Department, Faculty of PharmacyAin Shams University Cairo Egypt

2. Microbiology and Immunology Department, Faculty of PharmacyAin Shams University Cairo Egypt

3. Internal Medicine Department, Clinical Hematology division, Faculty of MedicineAin Shams University Cairo Egypt

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.13872

Reference26 articles.

1. Checkpoint blockade in cancer immunotherapy: squaring the circle;Maria AVM;Eur Med J Oncol,2015

2. Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia

3. Checkpoint Blockade in Cancer Immunotherapy

4. Immune checkpoint inhibitors: recent progress and potential biomarkers

5. Not All Immune Checkpoints Are Created Equal

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies;Cancer Communications;2024-07-28

2. Association of Polymorphisms in PD-1 and LAG-3 Genes with Acute Myeloid Leukemia;Medicina;2024-04-26

3. Construction of an immune-related prognostic signature and lncRNA–miRNA–mRNA ceRNA network in acute myeloid leukemia;Journal of Leukocyte Biology;2024-02-23

4. Effects of Combinatory In Vitro Treatment with Immune Checkpoint Inhibitors and Cytarabine on the Anti-Cancer Immune Microenvironment in De Novo AML Patients;Cancers;2024-01-22

5. Novel immune checkpoint targets: A promising therapy for cancer treatments;International Immunopharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3